{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:14:21Z","timestamp":1760609661101,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ejim.2022.11.030","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T15:22:39Z","timestamp":1669821759000},"page":"117-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hypersensitivity reactions associated with iron isomaltoside and ferric carboxymaltose"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3555-1550","authenticated-orcid":false,"given":"Carmelo","family":"Aguirre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itziar","family":"Palacios-Zabalza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Ceruelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ainhoa","family":"Txintxurreta-Albizua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7026-1079","authenticated-orcid":false,"given":"Montserrat","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2022.11.030_bib0001","unstructured":"EMA-CHMP report, 2020: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/intravenous-iron-containing-medicinal-products-article-31-referral-assessment-report_en.pdf."},{"key":"10.1016\/j.ejim.2022.11.030_bib0002","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/pds.5319","article-title":"Use of intravenous iron and risk of anaphylaxis: a multinational observational post-authorisation safety study in Europe","volume":"30","author":"Fortuny","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ejim.2022.11.030_bib0003","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-deficiency Anemia","volume":"323","author":"Wolf","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2022.11.030_bib0004","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/17474086.2020.1709437","article-title":"Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia","volume":"13","author":"Pollock","year":"2020","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.ejim.2022.11.030_bib0005","unstructured":"AEMPS report, 2020: https:\/\/www.aemps.gob.es\/informa\/notasinformativas\/medicamentosusohumano-3\/seguridad-1\/2017\/ni-muh_fv_08-2017-hierro_isomaltosido\/."},{"key":"10.1016\/j.ejim.2022.11.030_bib0006","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(77)91953-5","article-title":"Incidence and severity of anaphylactoid reactions to colloid volume substitutes","volume":"309","author":"Ring","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2022.11.030_bib0007","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/bcp.13189","article-title":"Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions","volume":"83","author":"Bager","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2022.11.030_bib0008","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/bcp.13805","article-title":"Comparison of hypersensitivity reactions of intravenous iron: iron isomaltoside-1000 (Monofer\u00ae) versus ferric carboxy-maltose (Ferinject\u00ae). A single center, cohort study","volume":"85","author":"Mulder","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejim.2022.11.030_bib0009","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1778-428X.2007.00042.x","article-title":"Adverse events associated with intravenous iron infusion (low-molecular-weight iron dextran and iron sucrose): a systematic review","volume":"9","author":"Critchly","year":"2007","journal-title":"Transfus Altern Transfus Med"},{"key":"10.1016\/j.ejim.2022.11.030_bib0010","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1111\/bph.13268","article-title":"Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management","volume":"172","author":"Szebeni","year":"2015","journal-title":"Br J Pharmacol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522004216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522004216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:38:10Z","timestamp":1760607490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620522004216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":10,"alternative-id":["S0953620522004216"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2022.11.030","relation":{},"ISSN":["0953-6205"],"issn-type":[{"type":"print","value":"0953-6205"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypersensitivity reactions associated with iron isomaltoside and ferric carboxymaltose","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2022.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}